Dextrose Monohydrate

Injection · trading as Dextrose

Current Active — Day 1550 FDA record updated 05/08/2026

Moderate impact — Limited manufacturing base (2 known suppliers); substitute sourcing may be constrained.

Editor of record: Branmoor Editorial · [email protected]

FDA shortage record

Substance

Dextrose Monohydrate

Brand name

Dextrose

Manufacturers / suppliers

ICU Medical, Inc.
Otsuka ICU Medical LLC

2 known suppliers in current FDA data

Dosage form

Injection

Presentation

Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-55)

Route(s)

INTRAVENOUS

Therapeutic category

Endocrinology/Metabolism, Gastroenterology, Other, Pediatric

Package NDC

0990-7922-55

Initially posted

02/14/2022

Days on shortage list

1550

Current FDA status

Current

Shortage entries (current dataset)

2 records for Dextrose Monohydrate

Reason and context

Reason reported: Other

On Allocation. ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical. Legacy Hospira NDC 0409-7922-55

Manufacturer contact

Per the FDA record, the manufacturer's contact for supply inquiries is 1-866-829-9025 or [email protected].

If you're affected by this shortage

Talk to your prescribing clinician or pharmacist about therapeutic alternatives. Do not switch medications on your own.
Ask your pharmacy to check supply across multiple wholesalers and other branches.
Check current pharmacy pricing and availability via GoodRx (affiliate link).
Report a continuing supply problem to FDA via the FDA Drug Shortages contact form.

Sources

FDA Drug Shortages database, accessed via the openFDA Drug Shortages API.
FDA Structured Product Label (SPL set ID 8b25b7e0-703e-4b43-a4eb-52863511602d).
FDA UNII identifier: LX22YL083G.
See the Drug Shortage Tracker methodology for sourcing, update cadence, normalization rules, and limits.

Important

This page reproduces publicly available FDA shortage data for informational purposes only. It is not medical advice and does not establish a clinician-patient relationship. Shortage status changes frequently; verify directly with your pharmacist or the FDA Drug Shortages site before making any treatment decision.